Roche to Buy Santaris Pharma

Roche will pay an initial $250 million and further payments of up to $200 million for the Danish biopharmaceutical company, which specializes in so-called RNA-targeting therapeutics



from WSJ.com: US Business http://ift.tt/WWJlR5

via IFTTT